| Views | |
|---|---|
| Iron(III)‐tCDTA derivatives as MRI contrast agents: Increased T 1 relaxivities at higher magnetic field strength and pH sensing | 128 |
| January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | |
|---|---|---|---|---|---|---|---|
| Iron(III)‐tCDTA derivatives as MRI contrast agents: Increased T 1 relaxivities at higher magnetic field strength and pH sensing | 0 | 9 | 4 | 13 | 0 | 3 | 2 |
| Views | |
|---|---|
| 2020_Xie_etal.pdf | 59 |
